|
V78794
|
14-3-3σ/ERα stabilizer-1
|
|
14-3-3σ/ERα stabler-1 (Compound 181) is a covalent 14-3-3σ/ERα stabilizer. |
|
V40395
|
Amcenestrant (SAR-439859)
|
2114339-57-8 |
Amcenestrant (SAR-439859; SAR439859) is a potent, orally available, and nonsteroidalestrogen receptor degrader (SERD)with potential anticancer activity. |
|
V77195
|
Bisphenol AF-d4 (BPAF-d4; 4,4'-(Perfluoropropane-2,2-diyl)diphenol-d4)
|
|
Bisphenol AF-d4 is an isotopically labeled analog of Bisphenol AF. |
|
V17164
|
BTC (Estrogen receptor modulator 1)
|
63676-22-2 |
BTC, formerly known as RALOXIFENE CORE, is a selective andorally active estrogen receptor modulator (SERM) with apIC50of 0.46. |
|
V79338
|
ERα degrader 6
|
|
ERα degrader 6 (Compound 31q) is an ERα degrader (KI: 75 nM). |
|
V78502
|
ERα degrader 7
|
|
ERα degrader 7 (Compound B1) is a potent ERα degrader with IC50 of 14.6 nM and a DC 50 of 9.7 nM. |
|
V79343
|
ET receptor antagonist 1
|
|
ET receptor antagonist 1 (compound 16h) is an ET receptor antagonist (IC50=0.18 nM) and may be utilized in pulmonary arterial hypertension (PAH) research. |
|
V79391
|
ET receptor antagonist 2
|
|
ET receptor antagonist 2 (compound 16j) is an ET receptor antagonist (IC50=0.22 nM) that may be utilized in pulmonary arterial hypertension (PAH) research. |
|
V78664
|
ET receptor antagonist 3
|
|
ET receptor antagonist 3 (compound 17d) is an ET receptor antagonist (IC50=0.26 nM) that may be utilized in pulmonary arterial hypertension (PAH) research. |
|
V79534
|
Fulvestrant-d3 (ICI 182780-d3; ZD 9238-d3; ZM 182780-d3)
|
|
Fulvestrant-d3 is the deuterium labelled form of Fulvestrant. |
|
V31869
|
H3B-5942
|
2052128-15-9 |
H3B-5942 (H3B5942) is a selective, irreversible (covalent) and orally bioavailable estrogen receptor antagonist with antitumor activity (better than fulvestrant). |
|
V76934
|
hFSH-β-(33-53) (TFA)
|
|
hFSH-β-(33-53) TFA is a thiol-containing peptide corresponding to the second FSH receptor-binding domain and is an FSHR (follicle-stimulating hormone receptor) antagonist. |
|
V81275
|
Raloxifene-d10
|
|
Raloxifene-d10 is the deuterated form of Raloxifene. |
|
V73484
|
Yp537 TFA (Anti-estrogen TFA)
|
|
Yp537 TFA is an estrogen receptor (ER) inhibitor that prevents dimerization of the human estrogen receptor. |
|
V1755
|
Sinomenine (Cucoline)
|
568-72-9 |
Sinomenine(Coculine; Cucoline; Kukoline) is a naturally occuring alkaloid found in the root of the climbing plant Sinomenium acutum which is native to Japan and China. |
|
V1752
|
Ulipristal (CDB-2914)
|
159811-51-5 |
Ulipristal(CDB-2914;HRP2000, VA2914,RTI 3021-012, RU 44675, EllaOne, Ella, Esmya) is a potent and selective SPRM (selective progesterone receptor modulator) used for emergency contraception after an unprotected intercourse or contraceptive failure. |
|
V1735
|
Ethinyl Estradiol (Ethynylestradiol)
|
57-63-6 |
Ethinyl Estradiol (17α-Ethynylestradiol; Ginestrene; Ethinyl Estradiol; Ethynylestradiol; Microfollin Forte; Organon; Progynon C) is an orally bioactive and semi-synthetic estrogen used in various formulations of combined oral contraceptive pills. |
|
V1756
|
Tariquidar dimesylate
|
625375-84-0 |
Tariquidar dimesylate (formerly known as XR9576; D06008; XR-9576; D-06008), the dimesylate salt ofTariquidar, is a novel potent and selective noncompetitive inhibitor of P-glycoprotein (P-gp) with potential antitumor activity. |
|
V10360
|
Dydrogesterone
|
152-62-5 |
Dydrogesterone is a synthetic progestin. |
|
V1733
|
Dehydroepiandrosterone (DHEA)
|
53-43-0 |
Dehydroepiandrosterone (trans-Dehydroandrosterone; DHEA; Prasterone; Psicosterone; EL-10; GL-701; IP-1001;NSC-9896;PB-007; SH-K-04828; Androstenolone; Diandrone) is an endogenous steroidal hormone acting asan androgen receptor antagonist and an estrogen receptor agonist. |